首页|吡非尼酮对肾纤维化大鼠的治疗作用及分子机制

吡非尼酮对肾纤维化大鼠的治疗作用及分子机制

Therapeutic effect and molecular mechanism of pirfenidone on the renal fibrosis rats

扫码查看
目的 探讨吡非尼酮(PFD)对肾纤维化大鼠肾脏的治疗作用及机制.方法 30只SD大鼠随机均分为对照组、模型组及治疗组,后2组大鼠腹腔注射50%四氯化碳(CCl4)油溶液建立肾纤维化模型,对照组腹腔注射等体积橄榄油,持续5周;造模结束,治疗组大鼠PFD水溶液灌胃给药,模型组和对照组大鼠同剂量生理盐水灌胃,持续4周;干预期间每天观察大鼠活动、进食饮水、毛发颜色以及大小便情况,于干预前以及干预第2、5、7及9周最后1次给药24 h后对大鼠进行称重并记录大鼠体质量及一般情况;干预第9周末处死各组大鼠,取心脏血检测血清尿素氮(BUN)、血肌酐(Scr)及尿酸(UA)含量,取肾脏组织采用苏木素伊红染色(HE)和Masson染色观察各组大鼠肾组织损伤和纤维化程度,采用蛋白免疫印迹法检测各组大鼠肾脏组织中沉默信息调节因子3(SIRT3)、缺氧诱导因子-1α(HIF-1α)、转化生长因子-β1(TGF-β1)、α平滑肌肌动蛋白(α-SMA)、Ⅰ型胶原(Col Ⅰ)、Ⅲ型胶原(Col Ⅲ)、金属蛋白酶组织抑制因子1(TIMP1)及基质金属蛋白酶2(MMP2)蛋白的表达.结果 与对照组比较,模型组大鼠肾功能损伤和纤维化明显,血清BUN、Scr及UA含量降低(P<0.05),肾组织中 HIF-1α、TGF-β1、α-SMA、Col Ⅰ、Col Ⅲ 及 TIMP1 蛋白表达增高(P<0.05),MMP2 和 SIRT3 蛋白表达降低(P<0.05);与模型组比较,治疗组大鼠肾功能损伤和纤维化程度减轻,血清肾功能BUN、Scr、UA含量增高(P<0.05),肾组织中 HIF-1α、TGF-β1、α-SMA、Col Ⅰ、Col Ⅲ及TIMP1 蛋白表达降低(P<0.05),MMP2 和 SIRT3 蛋白表达增高(P<0.05).结论 PFD可减轻肾纤维化大鼠肾功能损害和纤维化程度,其机制可能与上调SIRT3蛋白表达有关.
Objective To investigate the therapeutic effect and mechanism of pirfenidone(PFD)on kidney of rats with renal fibrosis.Methods Thirty SD rats were randomly divided into control group model group,and treatment group with equal number.The latter two groups were intraperitoneally injected with 50%CCl4 oil solution to establish a renal fibrosis model.The control group was intraperitoneally injected with the same dose of olive oil for 5 weeks.At the end of modeling,the treatment group rats were given PFD aqueous solution by gavage,while the model group and contro group were given the same dose of normal saline by gavage for 4 weeks.During the experiment,the activity,food and water intake,hair color,and bowel movements of rats were observed daily.The rats were weighed,their body mass and general condition were recorded before the experiment,and on the 2nd,5th,7th after intervention,and 24 h after the last dose of the 9th week.At the end of the 9th week of experiment,all groups of rats were euthanized.Heart blood was collected and tested for blood urea nitrogen(BUN),serum creatinine(Scr),and uric acid(UA)levels.Renal tissue was stained with Hematoxylin-Eosin(HE)and Masson's staining to observe the degree of renal tissue damage and fibrosis.Western Blot assay was adopted to test the expression of silence information regulator 3(SIRT3),hypoxia-inducible factor-1α(HIF-1α),transforming growth factor-β1(transforming growth factor-β1,(TGF-β1),Alpha-smooth muscle actin(α-SMA),Collagen type Ⅰ(Col Ⅰ),Collagen type Ⅲ(Col Ⅲ),tissue inhibitor of metalloproteinases 1(TIMP1),and Matrix metalloproteinases 2(MMP2).Results Compared with the control group,the model group showed significant renal function damage and fibrosis;serum BUN,SCR,and UA decreased(P<0.05);the expression level of HIF-1α,TGF-β1,α-SMA,Col Ⅰ,Col Ⅲ,and TIMP1 protein in renal tissue increased(P<0.05),the expression level of MMP2 and SIRT3 protein decreased(P<0.05).Compared with the model group,the treatment group showed reduced renal function damage and fibrosis,renal function BUN,SCR,and UA content increased(P<0.05);the expression level of HIF-1α,TGF-β1,α-SMA,Col Ⅰ,Col Ⅲ,and TIMP1 protein in renal tissue decreased(P<0.05),the expression level of MMP2 and SIRT3 protein increased(P<0.05).Conclusion PFD can alleviate renal function damage and fibrosis degree in rats with renal fibrosis,and its mechanism might be related to upregulation of SIRT3 protein expression.

carbon tetrachloridehypoxia-inducible factor 1,alpha subunittransforming growth factor beta1pirfenidonesilence information regulator 3renal fibrosis

晏青、程芝梅、张帅、周石

展开 >

贵州医科大学医学影像学院,贵州贵阳 550004

四氯化碳 缺氧诱导因子1,α亚基 转化生长因子β1 吡非尼酮 沉默信息调节因子3 肾纤维化

国家自然科学基金

81760325

2024

贵州医科大学学报
贵阳医学院

贵州医科大学学报

CSTPCD
影响因子:0.827
ISSN:2096-8388
年,卷(期):2024.49(3)
  • 30